Identification of the fusion peptide-containing region in betacoronavirus spike glycoproteins

Journal of Virology

Volumn 90, Issue 12, 2016, Pages 5586-5600

  Ou, Xiuyuan ^a   Zheng, Wangliang ^a   Shan, Yiwei ^a   Mu, Zhixia ^a   Dominguez, Samuel R ^b   Holmes, Kathryn V ^c   Qian, Zhaohui ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b Children's Hospital Colorado   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSION PEPTIDE; SPIKE GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; CORONAVIRUS SPIKE GLYCOPROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BETACORONAVIRUS; CELL FUSION; CONTROLLED STUDY; HYDROPHOBICITY; MEMBRANE FUSION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MURINE HEPATITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SARS CORONAVIRUS; SEQUENCE ANALYSIS; VIRUS ENTRY; ANIMAL; CHEMISTRY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOUSE; MUTATION; SEQUENCE ALIGNMENT; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; EVOLUTION, MOLECULAR; HEK293 CELLS; HUMANS; MEMBRANE FUSION; MICE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MURINE HEPATITIS VIRUS; MUTATION; PEPTIDES; SARS VIRUS; SEQUENCE ALIGNMENT; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRUS INTERNALIZATION;

EID: 84971455250     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00015-16     Document Type: Article

References (74)

1. Masters PS, Perlman S. 2013. Coronaviridae, p 825-858. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
2. King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (ed). 2011. Virus taxonomy. Classification and nomenclature of viruses. Ninth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA. http://ictvonline.org/virusTaxonomy.asp?version=2011.
3. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S. 2005. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102: 7988-7993. http://dx.doi.org/10.1073/pnas.0409465102.
4. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454. http://dx.doi.org/10.1038/nature02145.
5. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251-254. http://dx.doi.org/10.1038/nature12005.
6. Yang Y, Du L, Liu C, Wang L, Ma C, Tang J, Baric RS, Jiang S, Li F. 2014. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A 111:12516-12521. http://dx.doi.org/10.1073/pnas.1405889111.
7. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422. http://dx.doi.org/10.1038/357420a0.
8. Williams RK, Jiang GS, Holmes KV. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A 88:5533-5536. http://dx.doi.org/10.1073/pnas.88.13.5533.
9. Babcock GJ, Esshaki DJ, Thomas WD, Jr, Ambrosino DM. 2004. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78:4552-4560. http://dx.doi.org/10.1128/JVI.78.9.4552-4560.2004.
10. Wong SK, Li W, Moore MJ, Choe H, Farzan M. 2004. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensinconverting enzyme 2. J Biol Chem 279:3197-3201.
11. Li F, Berardi M, Li W, Farzan M, Dormitzer PR, Harrison SC. 2006. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol 80:6794-6800. http://dx.doi.org/10.1128/JVI.02744-05.
12. Harrison SC. 2015. Viral membrane fusion. Virology 479-480:498-507.
13. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43:189-219. http://dx.doi.org/10.1080/10409230802058320.
14. Bertram S, Glowacka I, Muller MA, Lavender H, Gnirss K, Nehlmeier I, Niemeyer D, He Y, Simmons G, Drosten C, Soilleux EJ, Jahn O, Steffen I, Pohlmann S. 2011. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsinlike protease. J Virol 85:13363-13372. http://dx.doi.org/10.1128/JVI.05300-11.
15. Millet JK, Whittaker GR. 2014. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A 111:15214-15219. http://dx.doi.org/10.1073/pnas.1407087111.
16. Belouzard S, Madu I, Whittaker GR. 2010. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. J Biol Chem 285:22758-22763. http://dx.doi.org/10.1074/jbc.M110.103275.
17. Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A 101:4240-4245. http://dx.doi.org/10.1073/pnas.0306446101.
18. Watanabe R, Matsuyama S, Shirato K, Maejima M, Fukushi S, Morikawa S, Taguchi F. 2008. Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol 82:11985-11991. http://dx.doi.org/10.1128/JVI.01412-08.
19. Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I, Welsch K, Winkler M, Schneider H, Hofmann-Winkler H, Thiel V, Pohlmann S. 2013. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 87:6150-6160. http://dx.doi.org/10.1128/JVI.03372-12.
20. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, Pohlmann S. 2011. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol 85:4122-4134. http://dx.doi.org/10.1128/JVI.02232-10.
21. Gallaher WR. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell 85:477-478. http://dx.doi.org/10.1016/S0092-8674(00)81248-9.
22. Hernandez LD, White JM. 1998. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroupA envelope glycoprotein. J Virol 72:3259-3267.
23. Delos SE, Gilbert JM, White JM. 2000. The central proline of an internal viral fusion peptide serves two important roles. J Virol 74:1686-1693. http://dx.doi.org/10.1128/JVI.74.4.1686-1693.2000.
24. Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, Peters CJ. 1998. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72:6442-6447.
25. Cross KJ, Langley WA, Russell RJ, Skehel JJ, Steinhauer DA. 2009. Composition and functions of the influenza fusion peptide. Protein Pept Lett 16:766-778. http://dx.doi.org/10.2174/092986609788681715.
26. Gallaher WR. 1987. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50:327-328. http://dx.doi.org/10.1016/0092-8674(87)90485-5.
27. Martin I, Ruysschaert JM. 2000. Common properties of fusion peptides from diverse systems. Biosci Rep 20:483-500. http://dx.doi.org/10.1023/A:1010454803579.
28. Guillen J, de Almeida RF, Prieto M, Villalain J. 2008. Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes. J Phys Chem B 112:6997-7007.
29. Guillen J, Kinnunen PK, Villalain J. 2008. Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein. Biochim Biophys Acta 1778:2765-2774. http://dx.doi.org/10.1016/j.bbamem.2008.07.021.
30. Guillen J, Perez-Berna AJ, Moreno MR, Villalain J. 2005. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism. J Virol 79:1743-1752. http://dx.doi.org/10.1128/JVI.79.3.1743-1752.2005.
31. Guillen J, Perez-Berna AJ, Moreno MR, Villalain J. 2008. A second SARS-CoV S2 glycoprotein internal membrane-active peptide. Biophysical characterization and membrane interaction. Biochemistry 47:8214-8224.
32. Madu IG, Roth SL, Belouzard S, Whittaker GR. 2009. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol 83:7411-7421. http://dx.doi.org/10.1128/JVI.00079-09.
33. Sainz B, Jr, Rausch JM, Gallaher WR, Garry RF, Wimley WC. 2005. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol 79:7195-7206. http://dx.doi.org/10.1128/JVI.79.11.7195-7206.2005.
34. Luo Z, Weiss SR. 1998. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology 244:483-494. http://dx.doi.org/10.1006/viro.1998.9121.
35. Chambers P, Pringle CR, Easton AJ. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol 71(Part 12):3075-3080. http://dx.doi.org/10.1099/0022-1317-71-12-3075.
36. Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD, Jr, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV. 2004. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 101:15748-15753. http://dx.doi.org/10.1073/pnas.0403812101.
37. Qian Z, Dominguez SR, Holmes KV. 2013. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One 8:e76469. http://dx.doi.org/10.1371/journal.pone.0076469.
38. Peng G, Sun D, Rajashankar KR, Qian Z, Holmes KV, Li F. 2011. Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. Proc Natl Acad Sci U S A 108:10696-10701. http://dx.doi.org/10.1073/pnas.1104306108.
39. Zelus BD, Schickli JH, Blau DM, Weiss SR, Holmes KV. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol 77:830-840. http://dx.doi.org/10.1128/JVI.77.2.830-840.2003.
40. Qian Z, Wang H, Empig C, Anderson WF, Albritton LM. 2004. Complementation of a binding-defective retrovirus by a host cell receptor mutant. J Virol 78:5766-5772. http://dx.doi.org/10.1128/JVI.78.11.5766-5772.2004.
41. Martin I, Schaal H, Scheid A, Ruysschaert JM. 1996. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol 70:298-304.
42. Chen YH, Yang JT, Chau KH. 1974. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism. Biochemistry 13:3350-3359. http://dx.doi.org/10.1021/bi00713a027.
43. Hope MJ, Bally MB, Webb G, Cullis PR. 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 812:55-65. http://dx.doi.org/10.1016/0005-2736(85)90521-8.
44. Struck DK, Hoekstra D, Pagano RE. 1981. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20:4093-4099. http://dx.doi.org/10.1021/bi00517a023.
45. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, Welsch K, Winkler M, Meyer B, Drosten C, Dittmer U, von Hahn T, Simmons G, Hofmann H, Pohlmann S. 2013. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 87:5502-5511. http://dx.doi.org/10.1128/JVI.00128-13.
46. Waring AJ, Mobley PW, Gordon LM. 1998. Conformational mapping of a viral fusion peptide in structure-promoting solvents using circular dichroism and electrospray mass spectrometry. Proteins 2:38-49.
47. Nelson JW, Kallenbach NR. 1986. Stabilization of the ribonuclease Speptide alpha-helix by trifluoroethanol. Proteins 1:211-217. http://dx.doi.org/10.1002/prot.340010303.
48. Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y, Geng H, Li H, Wang Q, Xiao H, Tan W, Yan J, Gao GF. 2013. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 87:13134-13140. http://dx.doi.org/10.1128/JVI.02433-13.
49. Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. 2014. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 5:3067.
50. Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ. 2004. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A 101:8455-8460. http://dx.doi.org/10.1073/pnas.0400576101.
51. Xu Y, Liu Y, Lou Z, Qin L, Li X, Bai Z, Pang H, Tien P, Gao GF, Rao Z. 2004. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem 279:30514-30522.
52. Xu Y, Lou Z, Liu Y, Pang H, Tien P, Gao GF, Rao Z. 2004. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J Biol Chem 279:49414-49419. http://dx.doi.org/10.1074/jbc.M408782200.
53. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77:8801-8811. http://dx.doi.org/10.1128/JVI.77.16.8801-8811.2003.
54. Kaufman G, Liu P, Leibowitz JL. 2014. Identification of novel functional regions within the spike glycoprotein of MHV-A59 based on a bioinformatics approach. Virus Res 189:177-188. http://dx.doi.org/10.1016/j.virusres.2014.05.023.
55. McRoy WC, Baric RS. 2008. Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion. J Virol 82:1414-1424. http://dx.doi.org/10.1128/JVI.01674-07.
56. Liao Y, Zhang SM, Neo TL, Tam JP. 2015. Tryptophan-dependent membrane interaction and heteromerization with the internal fusion peptide by the membrane proximal external region of SARS-CoV spike protein. Biochemistry 54:1819-1830. http://dx.doi.org/10.1021/bi501352u.
57. Li L, Vorobyov I, MacKerell AD, Jr, Allen TW. 2008. Is arginine charged in a membrane? Biophys J 94:L11-L13. http://dx.doi.org/10.1529/biophysj.107.121566.
58. Lai AL, Park H, White JM, Tamm LK. 2006. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity. J Biol Chem 281:5760-5770.
59. Li J, Das P, Zhou R. 2010. Single mutation effects on conformational change and membrane deformation of influenza hemagglutinin fusion peptides. J Phys Chem B 114:8799-8806. http://dx.doi.org/10.1021/jp1029163.
60. Li Y, Han X, Lai AL, Bushweller JH, Cafiso DS, Tamm LK. 2005. Membrane structures of the hemifusion-inducing fusion peptide mutant G1S and the fusion-blocking mutant G1V of influenza virus hemagglutinin suggest a mechanism for pore opening in membrane fusion. J Virol 79:12065-12076. http://dx.doi.org/10.1128/JVI.79.18.12065-12076.2005.
61. Lai AL, Freed JH. 2014. HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion. Biophys J 106:172-181. http://dx.doi.org/10.1016/j.bpj.2013.11.027.
62. Fuhrmans M, Marrink SJ. 2012. Molecular view of the role of fusion peptides in promoting positive membrane curvature. J Am Chem Soc 134:1543-1552. http://dx.doi.org/10.1021/ja207290b.
63. Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK. 2011. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad SciUSA108:11211-11216. http://dx.doi.org/10.1073/pnas.1104760108.
64. Lau WL, Ege DS, Lear JD, Hammer DA, DeGrado WF. 2004. Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization. Biophys J 86:272-284. http://dx.doi.org/10.1016/S0006-3495(04)74103-X.
65. Yang J, Prorok M, Castellino FJ, Weliky DP. 2004. Oligomeric betastructure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys J 87:1951-1963. http://dx.doi.org/10.1529/biophysj.103.028530.
66. Chang DK, Cheng SF, Kantchev EA, Lin CH, Liu YT. 2008. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol 6:2. http://dx.doi.org/10.1186/1741-7007-6-2.
67. Donald JE, Zhang Y, Fiorin G, Carnevale V, Slochower DR, Gai F, Klein ML, DeGrado WF. 2011. Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion. Proc Natl Acad Sci U S A 108:3958-3963. http://dx.doi.org/10.1073/pnas.1019668108.
68. Reuven EM, Dadon Y, Viard M, Manukovsky N, Blumenthal R, Shai Y. 2012. HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry 51:2867-2878. http://dx.doi.org/10.1021/bi201721r.
69. Teese MG, Langosch D. 2015. Role of GxxxG motifs in transmembrane domain interactions. Biochemistry 54:5125-5135. http://dx.doi.org/10.1021/acs.biochem.5b00495.
70. Faingold O, Cohen T, Shai Y. 2012. A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor. J Biol Chem 287:33503-33511. http://dx.doi.org/10.1074/jbc.M112.370817.
71. Chang DK, Cheng SF, Chien WJ. 1997. The amino-terminal fusion domain peptide of human immunodeficiency virus type 1 gp41 inserts into the sodium dodecyl sulfate micelle primarily as a helix with a conserved glycine at the micelle-water interface. J Virol 71:6593-6602.
72. Sackett K, Shai Y. 2005. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study. J Mol Biol 350:790-805. http://dx.doi.org/10.1016/j.jmb.2005.05.030.
73. Lorieau JL, Louis JM, Bax A. 2010. The complete influenza hemagglutinin fusion domain adopts a tight helical hairpin arrangement at the lipid: water interface. Proc Natl Acad Sci U S A 107:11341-11346. http://dx.doi.org/10.1073/pnas.1006142107.
74. Haria NR, Monticelli L, Fraternali F, Lorenz CD. 2014. Plasticity and conformational equilibria of influenza fusion peptides in model lipid bilayers. Biochim Biophys Acta 1838:1169-1179. http://dx.doi.org/10.1016/j.bbamem.2013.12.020.